Schedule 13G ownership disclosure
Ampio Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 03209T109
Event date: 2018-08-08
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,210,785
- Percent of class
- 1.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-18-051166
- Form type
- SC 13G
- Filer
- ACT CAPITAL MANAGEMENT, LLC
- CIK
- CIK 1442273
- Filed
- Aug 10, 2018
- Reporting period
- Aug 08, 2018
- Description
- Schedule 13G beneficial ownership